Who should receive extended infusion beta-lactam therapy?
Document Type
Article
Publication Date
2016
Abstract
The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.
Publication Title
Journal of the American Academy of Physician Assistants
Volume
29
Issue
3
First Page
25
Last Page
26
Recommended Citation
Roman, Christopher; Solh, Tia; and Damer, Kendra M., "Who should receive extended infusion beta-lactam therapy?" (2016). PCOM Scholarly Works. 1649.
https://digitalcommons.pcom.edu/scholarly_papers/1649
Comments
This article was published in Journal of the American Academy of Physician Assistants, Volume 29, Issue 3, Pages 25-26.
The published version is available at http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88.
Copyright © 2016 LWW.